EVENTS & PRESENTATIONS

Archived Events

Date	Event Details
Nov 6, 2018 8:30 AM EST	Regulus Announces Successful Restructuring of Sanofi Collaboration Click here for webcast
May 10, 2018 5:00 PM EDT	Regulus Therapeutics Inc. First Quarter 2018 Conference Call Listen to webcast
Mar 12, 2018 1:30 PM EDT	Cowen and Company 38th Annual Health Care Conference Listen to webcast
Mar 7, 2018 5:00 PM EST	Regulus Therapeutics Inc. Fourth Quarter 2017 Conference Call Listen to webcast
Jan 8, 2018	Corporate Presentation Corporate Presentation 2.4 MB
Nov 7, 2017 5:00 PM EST	Regulus Therapeutics Inc. Third Quarter 2017 Conference Call Listen to webcast
Sep 7, 2017 2:50 PM EDT	2017 Wells Fargo Healthcare Conference Location Boston, MA Listen to webcast
Aug 1, 2017 5:00 PM EDT	Regulus Therapeutics Inc. Second Quarter 2017 Conference Call Listen to webcast
May 4, 2017 5:00 PM EDT	Regulus Therapeutics Inc. First Quarter 2017 Conference Call Listen to webcast
Mar 7, 2017	Cowen and Company 37th Annual Health Care Conference View Presentation 3.8 MB
Mar 2, 2017 5:00 PM EST	Regulus Therapeutics Inc. Fourth Quarter 2016 Conference Call Listen to webcast
Dec 6, 2016 8:30 AM EST	Regulus Therapeutics Inc. R&D Day Listen to webcast View Presentation 6 MB
Nov 1, 2016 5:00 PM EDT	Regulus Therapeutics Inc. Third Quarter 2016 Conference Call Listen to webcast
Sep 7, 2016 2:55 PM EDT	2016 Wells Fargo Healthcare Conference
Aug 2, 2016 5:00 PM EDT	Regulus Therapeutics Inc. Second Quarter 2016 Conference Call Listen to webcast
Jun 27, 2016 5:00 PM EDT	Regulus Reports Clinical Hold of RG-101 Listen to webcast
Jun 10, 2016 12:30 PM EDT	Jefferies 2016 Healthcare Conference Listen to webcast
Jun 7, 2016 8:30 AM EDT	Regulus Therapeutics Inc. Conference Call Listen to webcast View Presentation 457.1 KB
May 25, 2016 8:00 AM EDT	UBS Global Healthcare Conference Location The Grand Hyatt, New York, NY Listen to webcast
May 12, 2016 9:20 AM PDT	Bank of America Merrill Lynch 2016 Health Care Conference Listen to webcast
May 2, 2016 5:00 PM EDT	Regulus Therapeutics Inc. First Quarter 2016 Conference Call Listen to webcast
Apr 15, 2016 8:00 AM EDT	Regulus Therapeutics Inc. Conference Call Listen to webcast View Presentation 1.1 MB
Apr 13-17, 2016	European Association for the Study of the Liver 51st Annual "International Liver Congress" Location Barcelona, Spain RG-101 DEMONSTRATES FAVORABLE IN VITRO ANTIVIRAL ACTIVITY AND CROSS RESISTANCE PROFILE TO SUPPORT CLINICAL COMBINATION STUDIES IN HCV PATIENTS 1.3 MB Sequence Analysis for Resistance Monitoring Following a Single Dose of RG-101, an anti-miR Targeting microRNA-122, in Chronic Hepatitis C Patients 914.5 KB A single dose with anti-miR122 oligonucleotide RG-101 results in a less activated phenotype of NK cells in patients with chronic hepatitis C 1 MB RG-101 in Combination with 4 Weeks of Oral Direct Acting Antiviral Therapy Achieves High Virologic Response Rates in Treatment Naïve Genotype 1 and 4 Chronic Hepatitis C Patients: Interim Results from a Randomised, Multi-Center, Phase 2 Study 701.8 KB
Feb 22, 2016 5:00 PM EST	Regulus Therapeutics, Inc. Fourth Quarter and Year-End 2015 Conference Call Listen to webcast
Feb 17, 2016 5:30 AM PST	Regulus Therapeutics Inc. Conference Call Listen to webcast RG-101 Phase II interim results 333.6 KB
Dec 15, 2015	Guggenheim 3rd Annual Boston Healthcare Conference
Dec 6-10, 2015	HEP DART 2015
Dec 3, 2015	Genetic Rx Conference
Nov 13-17, 2015	The Liver Meeting®, the 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD) Treatment with the Anti-miRNA122 Oligonucleotide RG-101 Results in a Decrease in IP-10 but Does Not Affect the Levels of Other Cytokines in Patients with Chronic Hepatitis C 541 KB A Single Dose of RG-101, a GalNAc-Conjugated Oligonucleotide Targeting miR-122, Results in Undetectable HCV RNA Levels in Chronic Hepatitis C Patients at Week 28 of Follow-up 1.4 MB
Nov 5, 2015 2:00 PM PST	Regulus Therapeutics Inc. Third Quarter 2015 Conference Call Listen to webcast
Nov 3-8, 2015	ASN Kidney Week 2015 Novel Methodology for Assessing Inhibition of MicroRNA-21 by RG-012, a MicroRNA Therapeutic in Development for the Treatment of Kidney Dysfunction in Patients with Alport Syndrome 265.2 KB Nonclinical Pharmacokinetics and Toxicokinetics of RG-012, an Inhibitor of MicroRNA-21 Being investigated for Treatment of Alport Syndrome 1.7 MB Discovery of Urine MicroRNA Biomarkers in a Pre-Clinical Model of Alport Nephropathy 2.3 MB
Sep 9-11, 2015	DIA/FDA Oligonucleotide-Based Therapeutic Conference 2015
Aug 11, 2015 1:55 PM EDT	Wedbush PacGrow Healthcare Conference Listen to webcast
Aug 4, 2015 2:00 PM PDT	Regulus Therapeutics Inc. Second Quarter 2015 Conference Call Listen to webcast
Jul 30, 2015	BMO Capital Markets San Francisco Biotech Corporate Access Day
May 7, 2015 2:00 PM PDT	Regulus Therapeutics Inc. First Quarter 2015 Conference Call Listen to webcast
May 6, 2015 11:20 AM EDT	Deutsche Bank 40th Annual Healthcare Conference Listen to webcast
Apr 22-26, 2015	European Association for the Study of the Liver 50th Annual "The International Liver Congress" Location Vienna, Austria A Single Subcutaneous Dose of 2 mg/kg or 4 mg/kg of RG-101, a Galnac-Conjugated Oligonucleotide with Antagonist Activity against miR-122, Results in Significant Viral Load Reductions in Chronic Hepatitis C Patients 2.8 MB PHARMACOKINETICS AND PHARMACOLOGY OF RG-101, A NOVEL GALNAC-CONJUGATED OLIGONUCLEOTIDE TARGETING MICRORNA-122, IN HEALTHY VOLUNTEERS 1 MB PHARMACOKINETICS, PHARMACODYNAMICS, AND TOXICITY PROFILE OF RG-101, A NOVEL GALNAC-CONJUGATED HEPATOCYTE-TARGETING INHIBITOR OF MICRORNA-122, IN RODENTS AND CYNOMOLGUS MONKEYS 1.2 MB RG-101, A NOVEL GALNAC-CONJUGATED INHIBITOR OF MICRORNA-122, DEMONSTRATES SIGNIFICANT VIRAL LOAD REDUCTION AND REDUCES LIVER STEATOSIS IN HUMAN HEPATOCYTE CHIMERIC MICE INFECTED WITH GENOTYPE 1A OR HARD-TO-TREAT GENOTYPE 3A HEPATITIS C VIRUS (HCV) 1.5 MB
Apr 19, 2015	Alport Syndrome Foundation 5K for Healthy Kidneys Location Arizona
Mar 4, 2015 9:20 AM EST	Cowen and Company 35th Annual Health Care Conference Listen to webcast
Feb 25, 2015 3:05 PM EST	2015 RBC Capital Markets' Healthcare Conference Listen to webcast

Achieve

EVENTS & PRESENTATIONS

Upcoming Events

Archived Events

Regulus Announces Successful Restructuring of Sanofi Collaboration

Regulus Therapeutics Inc. First Quarter 2018 Conference Call

Cowen and Company 38th Annual Health Care Conference

Regulus Therapeutics Inc. Fourth Quarter 2017 Conference Call

Corporate Presentation

Regulus Therapeutics Inc. Third Quarter 2017 Conference Call

2017 Wells Fargo Healthcare Conference

Location

Regulus Therapeutics Inc. Second Quarter 2017 Conference Call

Regulus Therapeutics Inc. First Quarter 2017 Conference Call

Cowen and Company 37th Annual Health Care Conference

Regulus Therapeutics Inc. Fourth Quarter 2016 Conference Call

Regulus Therapeutics Inc. R&D Day

Regulus Therapeutics Inc. Third Quarter 2016 Conference Call

2016 Wells Fargo Healthcare Conference

Regulus Therapeutics Inc. Second Quarter 2016 Conference Call

Regulus Reports Clinical Hold of RG-101

Jefferies 2016 Healthcare Conference

Regulus Therapeutics Inc. Conference Call

UBS Global Healthcare Conference

Location

Bank of America Merrill Lynch 2016 Health Care Conference

Regulus Therapeutics Inc. First Quarter 2016 Conference Call

Regulus Therapeutics Inc. Conference Call

European Association for the Study of the Liver 51st Annual "International Liver Congress"

Location

Regulus Therapeutics, Inc. Fourth Quarter and Year-End 2015 Conference Call

Regulus Therapeutics Inc. Conference Call

Guggenheim 3rd Annual Boston Healthcare Conference

HEP DART 2015

Genetic Rx Conference

The Liver Meeting&reg;, the 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

Regulus Therapeutics Inc. Third Quarter 2015 Conference Call

ASN Kidney Week 2015

DIA/FDA Oligonucleotide-Based Therapeutic Conference 2015

Wedbush PacGrow Healthcare Conference

Regulus Therapeutics Inc. Second Quarter 2015 Conference Call

BMO Capital Markets San Francisco Biotech Corporate Access Day

Regulus Therapeutics Inc. First Quarter 2015 Conference Call

Deutsche Bank 40th Annual Healthcare Conference

European Association for the Study of the Liver 50th Annual "The International Liver Congress"

Location

Alport Syndrome Foundation 5K for Healthy Kidneys

Location

Cowen and Company 35th Annual Health Care Conference

2015 RBC Capital Markets' Healthcare Conference

The Liver Meeting®, the 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)